Clinical Lab 2.0 Webinar Available On Demand Now

Clinical Lab 2.0 and the Future of Health Care

Health care sectors are transitioning from a fee-for-service payment system to new value-based payment models, and a new business model known as Clinical Lab 2.0 is leading the way. Clinical Lab 2.0 aims to support the transition of the US health care system from sick care to well care by providing meaningful interpretation of the clinical laboratory data. By delivering critical information in an actionable way, laboratorians can help optimize the diagnosis, treatment, and monitoring of patients while improving outcomes.requirements of the situation and shift their focus to those specific areas. In addition, crisis requires even more clear and precise communication than normal. It also requires leaders to be more open to feedback and help, to effectively take advantage of all the knowledge and experience in the team.
OnDemand Video Icon Available On Demand Now


Mark Fung.png
Mark Fung
Professor and Vice Chair of Population Health, Department of Pathology and Laboratory Medicine
University of Vermont Health Network
Monique Dodd.png
Monique Dodd
Manager, Enterprise Clinical Solutions
TriCore Reference Laboratories
Jordan Olson.png
Jordan Olson
Division Director, Clinical Pathology Informatics and Quality
Geisinger Medical Laboratories
Donna Wolk.png
Donna Wolk
Division Director
Geisinger Diagnostic Medicine Institute
Rick VanNess.png
Rick VanNess
Product Management - Director
TriCore Reference Laboratories

This webinar will provide you with background and tips on transitioning your lab from Clinical 1.0 to Clinical 2.0:
  • What is Clinical Lab 2.0?
  • Understanding the need for Clinical Lab 2.0
  • External forces impacting labs
  • PAMA
  • Value-based care
  • How to demonstrate the value of your lab
  • Hear from labs participating in Clinical Lab 2.0

Register Now for the On Demand Webinar

Clinical Lab 2.0 Webinar Registration

You must have Javascript and Cookies enabled to access this webcast.

For full details of how Binding Site will treat your information, please view their privacy policy



Binding Site is leading the way in special protein diagnostics with Freelite® serum free light chain assays, the market-leading and guideline-recommended free light chain test, and Optilite®, the smart solution for special protein testing. In addition to a menu of assays for the investigation of immune status, including Beta-2 microglobulin and CSF assays, Binding Site gives clinicians and laboratory staff the tools to significantly improve diagnosis and management of patients across a range of cancers and immune system disorders.